Corynebacterium, Kingella abundance tied to HNSCC risk

January 12, 2018

(HealthDay)—The overall oral microbiome composition is not associated with the risk of head and neck squamous cell carcinoma (HNSCC), but greater abundance of genera Corynebacterium and Kingella is associated with decreased HNSCC risk, according to a study published online Jan. 11 in JAMA Oncology.

Richard B. Hayes, D.D.S., Ph.D., from the New York University School of Medicine in New York City, and colleagues conducted a nested case- study in two prospective cohort studies to examine the correlation between the oral microbiome and incident HNSCC. A total of 129 patient cases of HNSCC were identified among 122,004 participants during an average follow-up of 3.9 years. Two controls were selected for each patient case (254 controls); cases and controls were similar in terms of age, sex, and race/ethnicity.

The researchers observed no for overall microbiome composition with the risk of HNSCC. Decreased risk of HNSCC was seen in association with greater abundance of genera Corynebacterium (fold change, 0.58) and Kingella (fold change, 0.63), which was possibly related to carcinogen metabolism capacity. The correlations tended to be stronger for larynx cancer and for those with tobacco use history.

"This study demonstrates that greater oral abundance of commensal Corynebacterium and Kingella is associated with decreased risk of HNSCC, with potential implications for cancer prevention," the authors write.

Explore further: High CVD risk in patients with head, neck squamous cell cancer

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

High CVD risk in patients with head, neck squamous cell cancer

February 2, 2017
(HealthDay)—Twenty-three percent of patients with head and neck squamous cell carcinoma (HNSCC) have cardiovascular disease (CVD) at diagnosis, and 24 percent have uncontrolled blood pressure, according to research published ...

Periodontitis linked to HPV-positive head, neck tumors

June 20, 2012
(HealthDay) -- For patients with head and neck squamous cell carcinoma (HNSCC) there is an increased risk of human papillomavirus (HPV)-positive tumors among those with a history of periodontitis, according to a study published ...

How head and neck squamous cell carcinomas take over wound-healing processes

November 29, 2017
A*STAR researchers have identified the molecular means by which a common form of cancer hijacks wound-healing processes to help it spread. The team hope their findings could lead to more effective treatments.

MED15 involved in head and neck squamous cell carcinoma

April 2, 2015
(HealthDay)—The mediator subunit MED15 appears to be involved in head and neck squamous cell carcinoma (HNSCC), according to a study published in the April issue of The American Journal of Pathology.

Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma

March 20, 2015
A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated ...

Sensitizing tumor cells to radiotherapy

March 1, 2012
Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer worldwide. Tumor resistance to radio- and/or chemotherapy remains a significant clinical problem.

Recommended for you

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.